Anthony J O'Donoghue Selected Research

procathepsin E

1/2016

Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony J O'Donoghue Research Topics

Disease

10	Infections 10/2020 - 10/2008
9	COVID-19 03/2022 - 10/2020
6	Neoplasms (Cancer) 01/2021 - 01/2016
5	Inflammation (Inflammations) 01/2021 - 04/2016
3	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2018
3	Malaria 12/2018 - 02/2016
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2019
2	Cysts 11/2019 - 08/2017
2	Pancreatic Cyst 11/2019 - 08/2017
2	Schistosomiasis (Bilharziasis) 10/2019 - 01/2018
1	Alcoholism (Alcohol Abuse) 06/2022
1	Cystic Fibrosis (Mucoviscidosis) 10/2020
1	Ventilator-Associated Pneumonia 10/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Parasitic Diseases (Parasitic Disease) 10/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Babesiosis (Piroplasmosis) 12/2018
1	Multiple Myeloma 01/2017
1	Disease Progression 01/2016
1	Adenocarcinoma 01/2016
1	Osteoporosis 01/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2012

Drug/Important Bio-Agent (IBA)

9	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2016
7	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2011
3	Antiviral Agents (Antivirals)IBA 03/2022 - 12/2020
3	Serine Proteases (Serine Protease)IBA 10/2021 - 01/2018
3	Cysteine Proteinase InhibitorsIBA 01/2021 - 10/2008
3	EnzymesIBA 01/2021 - 12/2016
3	Aspartic Acid ProteasesIBA 11/2019 - 01/2016
3	Proteasome InhibitorsIBA 11/2019 - 02/2016
3	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2019 - 01/2017
2	gallinamide AIBA 01/2022 - 12/2020
2	Cathepsin LIBA 01/2022 - 12/2020
2	Ac-GQFR-kbtIBA 10/2021 - 05/2021
2	Peptides (Polypeptides)IBA 01/2021 - 01/2019
2	Cysteine Proteases (Cysteine Protease)IBA 01/2021 - 01/2020
2	Cathepsin BIBA 01/2021 - 01/2020
2	Biological ProductsIBA 01/2020 - 01/2019
2	Cathepsin EIBA 08/2017 - 01/2016
1	Thiram FDA Link 06/2022
1	Disulfiram (Antabuse)FDA Link 06/2022
1	DisulfidesIBA 06/2022
1	Metalloproteases (Metalloproteinases)IBA 10/2020
1	Recombinant ProteinsIBA 10/2020
1	Virulence Factors (Pathogenicity Factors)IBA 10/2020
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020
1	Pancreatic Elastase (Elastase)IBA 01/2020
1	AminopeptidasesIBA 11/2019
1	Serine (L-Serine)FDA Link 11/2019
1	Tripeptidyl-Peptidase 1IBA 11/2019
1	matriptaseIBA 01/2019
1	Amino Acids FDA Link 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	HGF activatorIBA 01/2019
1	hepsinIBA 01/2019
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2019
1	epoxomicinIBA 12/2018
1	carfilzomibIBA 12/2018
1	Antimalarials (Antimalarial Agents)IBA 12/2018
1	Bortezomib (Velcade)FDA Link 12/2018
1	Boronic AcidsIBA 12/2018
1	PR-957IBA 12/2018
1	ixazomibIBA 12/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2018
1	VaccinesIBA 01/2018
1	AntigensIBA 01/2018
1	CytokinesIBA 11/2017
1	Histocompatibility Antigens Class IIBA 11/2017
1	carmaphycin BIBA 10/2017
1	gastricsinIBA 08/2017
1	Indicators and Reagents (Reagents)IBA 11/2016
1	InflammasomesIBA 08/2016
1	CaspasesIBA 04/2016
1	CathepsinsIBA 01/2016
1	procathepsin EIBA 01/2016
1	Ritonavir (Norvir)FDA Link 01/2016
1	Cathepsin KIBA 01/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2012
1	Viral ProteinsIBA 12/2011

Therapy/Procedure

3	Therapeutics 10/2020 - 11/2016